Literature DB >> 34689206

Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018.

Srinivas Gaddam1, Yazan Abboud1, Janice Oh2, Jamil S Samaan2, Nicholas N Nissen3, Shelly C Lu1, Simon K Lo1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34689206      PMCID： PMC8543346          DOI： 10.1001/jama.2021.18859

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Practical Considerations in Diagnosing and Managing Early-Onset GI Cancers.

Authors:  Melissa A Lumish; Andrea Cercek
Journal:  J Clin Oncol       Date:  2022-07-15       Impact factor: 50.717

Review 2.  Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome.

Authors:  Sheetal Hardikar; Mary C Playdon; Prasoona Karra; Maci Winn; Svenja Pauleck; Alicja Bulsiewicz-Jacobsen; Lacie Peterson; Adriana Coletta; Jennifer Doherty; Cornelia M Ulrich; Scott A Summers; Marc Gunter
Journal:  Obesity (Silver Spring)       Date:  2022-07       Impact factor: 9.298

Review 3.  Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.

Authors:  Raffaella Casolino; Vincenzo Corbo; Philip Beer; Chang-Il Hwang; Salvatore Paiella; Valentina Silvestri; Laura Ottini; Andrew V Biankin
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

4.  Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995-2018.

Authors:  Brian Z Huang; Lihua Liu; Juanjuan Zhang; Stephen J Pandol; Steven R Grossman; Veronica Wendy Setiawan
Journal:  Gastroenterology       Date:  2022-03-11       Impact factor: 33.883

5.  A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities.

Authors:  Jennifer B Permuth; Benjamin D Powers; Pamela J Hodul
Journal:  Gastroenterology       Date:  2022-05-02       Impact factor: 33.883

6.  The age-dependent association of risk factors with pancreatic cancer.

Authors:  C Yuan; J Kim; Q L Wang; A A Lee; A Babic; L T Amundadottir; A P Klein; D Li; M L McCullough; G M Petersen; H A Risch; R Z Stolzenberg-Solomon; K Perez; K Ng; E L Giovannucci; M J Stampfer; P Kraft; B M Wolpin
Journal:  Ann Oncol       Date:  2022-04-06       Impact factor: 51.769

7.  Risk factors related to age at diagnosis of pancreatic cancer: a retrospective cohort pilot study.

Authors:  Ro-Ting Lin; Pei-Lung Chen; Chi-Ying Yang; Chun-Chieh Yeh; Chun-Che Lin; Wen-Hsin Huang; An-Ko Chung; Jaw-Town Lin
Journal:  BMC Gastroenterol       Date:  2022-05-14       Impact factor: 2.847

8.  Updates on the Treatment of Pancreatic Diseases: Focus on Surgery, Electrochemotherapy and Rituximab.

Authors:  Romain Coriat; Anna Pellat
Journal:  J Clin Med       Date:  2022-01-03       Impact factor: 4.241

9.  Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment.

Authors:  Anna Pellat; Isabelle Boutron; Romain Coriat; Philippe Ravaud
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

10.  FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis.

Authors:  Kun Cai; Shiyu Chen; Changhao Zhu; Lin Li; Chao Yu; Zhiwei He; Chengyi Sun
Journal:  Cell Death Dis       Date:  2022-09-03       Impact factor: 9.685
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.